Nanophase reports record FY2022 revenue $37.3M (+27% YoY) but net loss of $2.6M

SOLESENCE, INC.

FY2022 revenue $37.3M, up 27% YoY; Q4 revenue $8.3M, up 12% YoY.
Net loss $2.6M ($0.05/sh) vs net income $2.3M ($0.05/sh) in 2021.
Solésence revenue $23.1M (+27%); Personal Care Ingredients $11.1M (+44%); Advanced Materials $3.1M (-14%).
Atypical expenses $1.6M: $0.7M cyber theft loss, $0.4M litigation legal fees, $0.3M bad debt.
Received US patent allowance for Kleair skin health tech; named No.2 in Fast Company Beauty innovation list.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.